Imsidolimab: an emerging biological therapy for generalized pustular psoriasis
Br J Dermatol
.
2023 Jul 17;189(2):153.
doi: 10.1093/bjd/ljad128.
Authors
David Gleeson
1
,
Satveer K Mahil
1
Affiliation
1
St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
PMID:
37079741
DOI:
10.1093/bjd/ljad128
No abstract available
Publication types
Editorial
Comment
MeSH terms
Acute Disease
Antibodies, Monoclonal
Biological Therapy
Chronic Disease
Humans
Psoriasis* / drug therapy
Substances
Antibodies, Monoclonal
Grants and funding
National Institute for Health and Care Research (NIHR)
NIHR302258/NIHR Advanced Fellowship